Phosphodiesterase 5 inhibitors prevent 3,4‐methylenedioxymethamphetamine‐induced 5‐HT deficits in the rat

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Neurochemistry

• Publication date

  2009-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1471-4159.2008.05825.xPMID 19187094
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The mitochondrial K[ATP] channel opener BMS-191095 reduces neuronal damage after transient focal cerebral ischemia in rats

  2009cited by this paper
• Molecular physiology of preconditioning-induced brain tolerance to ischemia.

  2008cited by this paper
• Oral phosphodiesterase type 5 inhibitors: nonerectogenic beneficial uses.

  2008cited by this paper
• The relationship between core body temperature and 3,4-methylenedioxymethamphetamine metabolism in rats: implications for neurotoxicity

  2008cited by this paper
• Magnetic Resonance Imaging Investigation of Axonal Remodeling and Angiogenesis after Embolic Stroke in Sildenafil-Treated Rats

  2008cited by this paper
• Minoxidil prevents 3,4‐methylenedioxymethamphetamine‐induced serotonin depletions: role of mitochondrial ATP‐sensitive potassium channels, Akt and ERK

  2008cited by this paper
• Involvement of PI3K/PKG/ERK1/2 signaling pathways in cortical neurons to trigger protection by cotreatment of acetyl-L-carnitine and alpha-lipoic acid against HNE-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease.

  2007cited by this paper
• Dose translation from animal to human studies revisited

  2007cited by this paper
• Studies on the mechanisms underlying amiloride enhancement of 3,4-methylenedioxymethamphetamine-induced serotonin depletion in rats.

  2007cited by this paper
• Sildenafil and vardenafil but not nitroglycerin limit myocardial infarction through opening of mitochondrial K(ATP) channels when administered at reperfusion following ischemia in rabbits.

  2007cited by this paper
• Methamphetamine and sildenafil (Viagra) use are linked to unprotected receptive and insertive anal sex, respectively, in a sample of men who have sex with men

  2006cited by this paper
• MDMA‐induced neurotoxicity: long‐term effects on 5‐HT biosynthesis and the influence of ambient temperature

  2006cited by this paper
• Cardioprotection with sildenafil: implications for clinical practice.

  2006cited by this paper
• The Mitochondrial KATP Channel Opener BMS-191095 Reduces Neuronal Damage after Transient Focal Cerebral Ischemia in Rats

  2006cited by this paper
• Studies on striatal neurotoxicity caused by the 3,4-methylenedioxymethamphetamine/ malonate combination: implications for serotonin/dopamine interactions

  2006cited by this paper
• Pharmacological preconditioning with sildenafil: Basic mechanisms and clinical implications.

  2005cited by this paper
• Sildenafil use, sexual risk behavior, and risk for sexually transmitted diseases, including HIV infection.

  2005cited by this paper
• Evidence for the Involvement of Nitric Oxide in 3,4-Methylenedioxymethamphetamine-Induced Serotonin Depletion in the Rat Brain

  2005cited by this paper
• Recreational use and misuse of phosphodiesterase 5 inhibitors.

  2005cited by this paper
• Quantitative PET Studies of the Serotonin Transporter in MDMA Users and Controls Using [11C]McN5652 and [11C]DASB

  2005cited by this paper
• Protein Kinase G Transmits the Cardioprotective Signal From Cytosol to Mitochondria

  2005cited by this paper
• Activation of the PI3-K/Akt Pathway Mediates cGMP Enhanced-Neurogenesis in the Adult Progenitor Cells Derived from the Subventricular Zone

  2005cited by this paper
• Diazoxide preconditioning protects against neuronal cell death by attenuation of oxidative stress upon glutamate stimulation

  2004cited by this paper
• Stimulation of serotonin transport by the cyclic GMP phosphodiesterase-5 inhibitor sildenafil.

  2004cited by this paper
• Effect of Repeated (‘Binge’) Dosing of MDMA to Rats Housed at Normal and High Temperature on Neurotoxicdamage to Cerebral 5-Ht and Dopamine Neurones

  2004cited by this paper
• Activation of the cGMP Pathway in Dopaminergic Structures Reduces Cocaine-Induced EGR-1 Expression and Locomotor Activity

  2004cited by this paper
• Adenosine receptor, protein kinase G, and p38 mitogen-activated protein kinase-dependent up-regulation of serotonin transporters involves both transporter trafficking and activation.

  2004cited by this paper
• Protein kinase C plays an essential role in sildenafil-induced cardioprotection in rabbits.

  2004cited by this paper
• Studies on the role of dopamine D1 receptors in the development and expression of MDMA-induced behavioral sensitization in rats

  2004cited by this paper
• The mitochondrial KATP channel opener BMS-191095 induces neuronal preconditioning

  2004cited by this paper
• Cardioprotection with phosphodiesterase-5 inhibition--a novel preconditioning strategy.

  2004cited by this paper
• Cyclic GMP-dependent Protein Kinase Regulates the Expression of Thioredoxin and Thioredoxin Peroxidase-1 during Hormesis in Response to Oxidative Stress-induced Apoptosis*

  2003cited by this paper
• 17β‐Estradiol activates ICI 182,780‐sensitive estrogen receptors and cyclic GMP‐dependent thioredoxin expression for neuroprotection

  2003cited by this paper
• The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)

  2003cited by this paper
• Hypothalamic-Pituitary-Thyroid Axis and Sympathetic Nervous System Involvement in Hyperthermia Induced by 3,4-Methylenedioxymethamphetamine (Ecstasy)

  2003cited by this paper
• Signaling through NO and cGMP‐dependent protein kinases

  2003cited by this paper
• Diazoxide induces delayed pre‐conditioning in cultured rat cortical neurons

  2003cited by this paper
• Demonstration and localization of neuronal degeneration in the rat forebrain following a single exposure to MDMA.

  2003cited by this paper
• Mitochondrial ATP-Sensitive Potassium Channel Activation Protects Cerebellar Granule Neurons From Apoptosis Induced by Oxidative Stress

  2003cited by this paper
• MitoK(ATP) opener, diazoxide, reduces neuronal damage after middle cerebral artery occlusion in the rat.

  2002cited by this paper
• Activation of Mitochondrial ATP-Dependent Potassium Channels Protects Neurons against Ischemia-Induced Death by a Mechanism Involving Suppression of Bax Translocation and Cytochrome c Release

  2002cited by this paper
• MitoKATP opener, diazoxide, reduces neuronal damage after middle cerebral artery occlusion in the rat

  2002cited by this paper
• Sildenafil (Viagra) Induces Neurogenesis and Promotes Functional Recovery After Stroke in Rats

  2002cited by this paper
• Neurologic, Psychological, and Aggressive Disturbances with Sildenafil

  2002cited by this paper
• Sildenafil (Viagra) induces powerful cardioprotective effect via opening of mitochondrial K(ATP) channels in rabbits.

  2002influential reference
• The mechanisms involved in the long‐lasting neuroprotective effect of fluoxetine against MDMA (‘ecstasy’)‐induced degeneration of 5‐HT nerve endings in rat brain

  2001cited by this paper
• Serotonergic deficits and impaired passive-avoidance learning in rats by MDEA: a comparison with MDMA.

  2000cited by this paper
• 2‐Deoxy‐D‐Glucose Prevents and Nicotinamide Potentiates 3,4‐Methylenedioxymethamphetamine‐Induced Serotonin Neurotoxicity

  2000cited by this paper
• Immunohistochemical Localization of cGMP-binding cGMP-specific Phosphodiesterase (PDE5) in Rat Tissues

  2000cited by this paper
• Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation

  1999cited by this paper
• Alpha-lipoic acid prevents 3,4-methylenedioxy-methamphetamine (MDMA)-induced neurotoxicity.

  1999cited by this paper
• Altered Serotonin Innervation Patterns in the Forebrain of Monkeys Treated with (±)3,4-Methylenedioxymethamphetamine Seven Years Previously: Factors Influencing Abnormal Recovery

  1999cited by this paper
• Cyclic GMP Phosphodiesterase-5: Target of Sildenafil*

  1999cited by this paper
• Involvement of the serotonin transporter in the formation of hydroxyl radicals induced by 3,4-methylenedioxymethamphetamine.

  1999cited by this paper
• Regulation of endothelium-derived nitric oxide production by the protein kinase Akt

  1999cited by this paper
• MDMA ('Ecstasy') enhances 5-HT1A receptor density and 8-OH-DPAT-induced hypothermia: blockade by drugs preventing 5-hydroxytryptamine depletion.

  1998cited by this paper
• Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction

  1995cited by this paper
• Nitric oxide signaling in the central nervous system.

  1995cited by this paper
• International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).

  1994cited by this paper
• Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity

  1988cited by this paper
• Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain.

  1987cited by this paper
• Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine.

  1987cited by this paper
• The primate serotonergic system: a review of human and animal studies and a report on Macaca fascicularis.

  1986cited by this paper
• INTERNATIONAL SOCIETY FOR NEUROCHEMISTRY

  1976cited by this paper

• Two tales of therapeutic innovations for Leigh syndrome spectrum

  2025cites this paper
• Natural products proposed for the management of Huntington’s disease (HD): a comprehensive review

  2025cites this paper
• Cell surface receptor-mediated signaling in CNS regeneration.

  2024cites this paper
• Emerging phosphodiesterase inhibitors for treatment of neurodegenerative diseases

  2024cites this paper
• The Effect of Chronic Treatment with the Inhibitor of Phosphodiesterase 5 (PDE5), Sildenafil, in Combination with L-DOPA on Asymmetric Behavior and Monoamine Catabolism in the Striatum and Substantia Nigra of Unilaterally 6-OHDA-Lesioned Rats

  2024cites this paper
• A review on the mitochondrial toxicity of “ecstasy” (3,4-methylenedioxymethamphetamine, MDMA)

  2022cites this paper
• A review on the mitochondrial toxicity of “ecstasy” (3,4-methylenedioxymethamphetamine, MDMA)

  2022cites this paper
• Increased iNOS and Nitrosative Stress in Dopaminergic Neurons of MDMA-Exposed Rats

  2019cites this paper
• Inhibition of phosphodiesterases as a strategy to achieve neuroprotection in Huntington's disease

  2018cites this paper
• Increased motor neuron resilience by small molecule compounds that regulate IGF-II expression.

  2018influential citation
• Mechanisms Involved in the Remyelinating Effect of Sildenafil

  2017cites this paper
• SIRT2 inhibition modulate glutamate and serotonin systems in the prefrontal cortex and induces antidepressant‐like action

  2017cites this paper
• The role of sildenafil in the development of transplant arteriosclerosis in rat aortic grafts.

  2017cites this paper
• The Role of NO/cGMP Signaling on Neuroinflammation: A New Therapeutic Opportunity

  2017cites this paper
• Role of Phosphodiesterases in Huntington's Disease.

  2017cites this paper
• Phosphodiesterases: CNS Functions and Diseases

  2017cites this paper
• MDMA decreases glutamic acid decarboxylase (GAD) 67-immunoreactive neurons in the hippocampus and increases seizure susceptibility: Role for glutamate.

  2016cites this paper
• Pharmacokinetic investigation of sildenafil using positron emission tomography and determination of its effect on cerebrospinal fluid cGMP levels

  2016cites this paper
• Novel Radioligands for Cyclic Nucleotide Phosphodiesterase Imaging with Positron Emission Tomography: An Update on Developments Since 2012

  2016cites this paper
• Sildenafil Decreases BACE 1 and Cathepsin B Levels and Reduces APP Amyloidogenic Processing in the SAMP 8 Mouse

  2015influential citation
• Sildenafil Decreases BACE1 and Cathepsin B Levels and Reduces APP Amyloidogenic Processing in the SAMP8 Mouse.

  2015cites this paper
• Phosphodiesterases as therapeutic targets for Huntington's disease.

  2014cites this paper
• Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions.

  2014influential citation
• Inhibition of Cyclic Nucleotide Phosphodiesterases to Regulate Memory

  2014cites this paper
• Estudio de las principales vías responsables del efecto terapéutico del sildenafilo sobre el deterioro cognitivo del ratón de senescencia acelerada SAMP8

  2014cites this paper
• Modulation of the ASK1–MKK3/6–p38/MAPK signalling pathway mediates sildenafil protection against chemical hypoxia caused by malonate

  2013cites this paper
• Metallothioneins I/II are involved in the neuroprotective effect of sildenafil in focal brain injury.

  2013cites this paper
• Phosphodiesterases: Regulators of cyclic nucleotide signals and novel molecular target for movement disorders.

  2013cites this paper
• Regulation of Hippocampal cGMP Levels as a Candidate to Treat Cognitive Deficits in Huntington’s Disease

  2013cites this paper
• Inhibition of calpain-regulated p35/cdk5 plays a central role in sildenafil-induced protection against chemical hypoxia produced by malonate.

  2013cites this paper
• Mechanisms underlying altered striatal synaptic plasticity in old A53T-α synuclein overexpressing mice.

  2012cites this paper
• A Review on the Potential Benefits of Phosphodiesterase Inhibitors in Various Models of Toxicities in Animals

  2012cites this paper
• Regulation of neuroinflammation by cGMP-mediated pathways.

  2012cites this paper
• The NMDA receptor subunit GluN3A protects against 3-nitroproprionic-induced striatal lesions via inhibition of calpain activation.

  2012cites this paper
• Sildenafil, a phosphodiesterase type 5 inhibitor, enhances the activity of two atypical antidepressant drugs, mianserin and tianeptine, in the forced swim test in mice.

  2012cites this paper
• Long‐lasting neuroprotective effect of sildenafil against 3,4‐methylenedioxymethamphetamine‐ induced 5‐hydroxytryptamine deficits in the rat brain

  2012influential citation
• Sildenafil ameliorates cognitive deficits and tau pathology in a senescence-accelerated mouse model.

  2012cites this paper
• Sildenafil Reduces Insulin-Resistance in Human Endothelial Cells

  2011cites this paper
• Mitochondria: the headquarters in ischemia-induced neuronal death.

  2011cites this paper
• Methylenedioxymethamphetamine (MDMA, ‘Ecstasy’): Neurodegeneration versus Neuromodulation

  2011cites this paper
• Sildenafil restores cognitive function without affecting β‐amyloid burden in a mouse model of Alzheimer's disease

  2011cites this paper
• Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia.

  2011cites this paper
• Role of Neuropeptide Y in Depression: Current Status

  2011cites this paper
• Sildenafil protects against 3-nitropropionic acid neurotoxicity through the modulation of calpain, CREB, and BDNF.

  2010cites this paper
• Delayed pre‐conditioning by 3‐nitropropionic acid prevents 3,4‐methylenedioxymetamphetamine‐induced 5‐HT deficits

  2010influential citation
• Mechanisms mediating the ability of caffeine to influence MDMA (‘Ecstasy’)‐induced hyperthermia in rats

  2010cites this paper
• On the Mechanisms Underlying 3,4-Methylenedioxymethamphetamine Toxicity: The Dilemma of the Chicken and the Egg

  2009cites this paper